Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1310398
European Journal of Endocrinology, Vol 131, Issue 4, 398-404
Copyright © 1994 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gallaher, B.
Right arrow Articles by Breier, B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Gallaher, B.
Right arrow Articles by Breier, B.

Circulating insulin-like growth factor II/mannose-6-phosphate receptor and insulin-like growth factor binding proteins in fetal sheep plasma are regulated by glucose and insulin

BW Gallaher, MH Oliver, K Eichhorn, U Kessler, W Kiess, JE Harding, PD Gluckman and BH Breier

Gallaher BW, Oliver MH, Eichhorn K, Kessler U, Kiess W, Harding JE, Gluckman PD, Breier BH. Circulating insulin-like growth factor II/mannose-6-phosphate receptor and insulin-like growth factor binding proteins in fetal sheep plasma are regulated by glucose and insulin. Eur J Endocrinol 1994; 131:398–404. ISSN 0804–4643

We have reported previously that levels of insulin-like growth factor I (IGF-I) and IGF-II in fetal sheep plasma decrease with maternal starvation and increase following an infusion of glucose to the starved fetus, while a fetal infusion of insulin elevates UGF-I alone. We now report the changes in the circulating IGF-II/M6P receptor and plasma IGF binding proteins (IGFBPs), as measured by western blotting and ligand blotting, respectively, in fetus and mother during this study. In fetal plasma, the circulating IGF-II/mannose-6-phosphate (M6P) receptor, IGFBP-3 and IGFBP-4 were reduced during starvation. While circulating IGF-II/M6P receptor and IGFBP-4 levels were increased following the fetal insulin or glucose infusion, IGFBP-3 was unchanged and increased only after 48 h of maternal refeeding. Both IGFBP-1 and IGFBP-2 increased with starvation but while IGFBP-1 levels returned to control values following both insulin and glucose infusion, levels of IGFBP-2 were not reduced significantly by either infusion or by refeeding. In maternal plasma, levels of IGFBP-3 and IGFBP-4 decreased while IGFBP-1 and IGFBP-2 increased after 48 h of starvation. Levels of each IGFBP were unaltered following the fetal infusions but returned to values obtained during the control period after refeeding. These data show that each of the IGF carrier proteins is sensitive of changes in nutrition, either acutely, such as IGFBP-1, or chronically, as for IGFBP-3. This suggests that the circulating IGFII/M6P receptor and the IGFBP's may modulate IGF activity in the fetus during different nutritional states.

BH Breier, Research Centre for Developmental Medicine and Biology, Department of Paediatrics, School of Medicine, University of Auckland, Private Bag 92019, Auckland, New Zealand




This article has been cited by other articles:


Home page
J. Nutr.Home page
P. D. Gluckman and C. S. Pinal
Regulation of Fetal Growth by the Somatotrophic Axis
J. Nutr., May 1, 2003; 133(5): 1741S - 1746.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
L. R. Green
Programming of Endocrine Mechanisms of Cardiovascular Control and Growth
Reproductive Sciences, April 1, 2001; 8(2): 57 - 68.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Costello, R. C. Baxter, and C. D. Scott
Regulation of Soluble Insulin-Like Growth Factor II/Mannose 6-Phosphate Receptor in Human Serum: Measurement by Enzyme-Linked Immunosorbent Assay
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 611 - 617.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Gaither, A. N. Quraishi, and N. P. Illsley
Diabetes Alters the Expression and Activity of the Human Placental GLUT1 Glucose Transporter
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 695 - 701.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. I. Tazuke, N. M. Mazure, J. Sugawara, G. Carland, G. H. Faessen, L.-F. Suen, J. C. Irwin, D. R. Powell, A. J. Giaccia, and L. C. Giudice
Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: A possible model for IGFBP-1 expression in fetal hypoxia
PNAS, August 18, 1998; 95(17): 10188 - 10193.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Linnell, G. Groeger, and A. B. Hassan
Real Time Kinetics of Insulin-like Growth Factor II (IGF-II) Interaction with the IGF-II/Mannose 6-Phosphate Receptor. THE EFFECTS OF DOMAIN 13 AND pH
J. Biol. Chem., June 22, 2001; 276(26): 23986 - 23991.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 European Society of Endocrinology.